Announcements Trials

Browse Landscape

Phase

Status

Unknown 4 Completed 3 Recruiting 2 Withdrawn 1 Terminated 1 Suspended 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Leukemia 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Tissue Adhesions 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 NSCLC 1 Multiple Myeloma 1 Mucositis 1 Malnutrition 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Glioblastoma 1 Fatigue 1 Fasting Mimicking Diet 1 Eyelid Squamous Cell Carcinoma 1 Endometriosis 1

Interventions

HM781-36B 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Suspended × NSCLC × Clear all

NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡